Logo image of SGMS

SCIENTIFIC GAMES CORP (SGMS) Stock Fundamental Analysis

NASDAQ:SGMS - Nasdaq - US80874P1093 - Common Stock

58.07  +1.32 (+2.33%)

After market: 58.07 0 (0%)

Fundamental Rating

2

Taking everything into account, SGMS scores 2 out of 10 in our fundamental rating. SGMS was compared to 135 industry peers in the Hotels, Restaurants & Leisure industry. SGMS may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, SGMS is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

SGMS had positive earnings in the past year.
SGMS Yearly Net Income VS EBIT VS OCF VS FCFSGMS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 500M -500M -1B

1.2 Ratios

Industry RankSector Rank
ROA 4.52%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SGMS Yearly ROA, ROE, ROICSGMS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 20 40 60 80

1.3 Margins

Industry RankSector Rank
OM 13.15%
PM (TTM) 12.35%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SGMS Yearly Profit, Operating, Gross MarginsSGMS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 20 -20 40 -40 60

More info and screens

2

2. Health

2.1 Basic Checks

The number of shares outstanding for SGMS has been increased compared to 1 year ago.
The debt/assets ratio for SGMS has been reduced compared to a year ago.
SGMS Yearly Shares OutstandingSGMS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 20M 40M 60M 80M
SGMS Yearly Total Debt VS Total AssetsSGMS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2B 4B 6B 8B

2.2 Solvency

SGMS has an Altman-Z score of 0.37. This is a bad value and indicates that SGMS is not financially healthy and even has some risk of bankruptcy.
SGMS has a Debt/Equity ratio of -3.83. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity -3.83
Debt/FCF N/A
Altman-Z 0.37
ROIC/WACCN/A
WACCN/A
SGMS Yearly LT Debt VS Equity VS FCFSGMS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 2B -2B 4B 6B 8B

2.3 Liquidity

SGMS has a Current Ratio of 1.78. This is a normal value and indicates that SGMS is financially healthy and should not expect problems in meeting its short term obligations.
A Quick Ratio of 1.68 indicates that SGMS should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.78
Quick Ratio 1.68
SGMS Yearly Current Assets VS Current LiabilitesSGMS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 500M 1B 1.5B 2B

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 166.95% over the past year.
Looking at the last year, SGMS shows a small growth in Revenue. The Revenue has grown by 5.80% in the last year.
Measured over the past years, SGMS shows a decrease in Revenue. The Revenue has been decreasing by -5.67% on average per year.
EPS 1Y (TTM)166.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%200%
Revenue 1Y (TTM)5.8%
Revenue growth 3Y-13.82%
Revenue growth 5Y-5.67%
Sales Q2Q%-23.75%

3.2 Future

The Earnings Per Share is expected to grow by 13.52% on average over the next years. This is quite good.
SGMS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.78% yearly.
EPS Next Y-61%
EPS Next 2Y-8.45%
EPS Next 3Y-7.2%
EPS Next 5Y13.52%
Revenue Next Year-10.08%
Revenue Next 2Y-0.9%
Revenue Next 3Y-0.83%
Revenue Next 5Y0.78%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SGMS Yearly Revenue VS EstimatesSGMS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1B 2B 3B
SGMS Yearly EPS VS EstimatesSGMS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 5 -5 -10

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 18.49, which indicates a rather expensive current valuation of SGMS.
Compared to an average S&P500 Price/Earnings ratio of 26.68, SGMS is valued a bit cheaper.
The Price/Forward Earnings ratio is 47.42, which means the current valuation is very expensive for SGMS.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.50, SGMS is valued quite expensively.
Industry RankSector Rank
PE 18.49
Fwd PE 47.42
SGMS Price Earnings VS Forward Price EarningsSGMS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 17.68
SGMS Per share dataSGMS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 -20

4.3 Compensation for Growth

A cheap valuation may be justified as SGMS's earnings are expected to decrease with -7.20% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-8.45%
EPS Next 3Y-7.2%

More info and screens

0

5. Dividend

5.1 Amount

SGMS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SCIENTIFIC GAMES CORP

NASDAQ:SGMS (4/28/2022, 8:26:43 PM)

After market: 58.07 0 (0%)

58.07

+1.32 (+2.33%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)03-01 2022-03-01/amc
Earnings (Next)05-10 2022-05-10/amc
Inst Owners64.71%
Inst Owner Change-0.89%
Ins Owners2.74%
Ins Owner Change0%
Market Cap5.63B
Analysts76.92
Price Target77.65 (33.72%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 18.49
Fwd PE 47.42
P/S 1.95
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 17.68
EPS(TTM)3.14
EY5.41%
EPS(NY)1.22
Fwd EY2.11%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS29.71
BVpS-23.26
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.52%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 13.15%
PM (TTM) 12.35%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity -3.83
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.78
Quick Ratio 1.68
Altman-Z 0.37
F-Score8
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)166.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%200%
EPS Next Y-61%
EPS Next 2Y-8.45%
EPS Next 3Y-7.2%
EPS Next 5Y13.52%
Revenue 1Y (TTM)5.8%
Revenue growth 3Y-13.82%
Revenue growth 5Y-5.67%
Sales Q2Q%-23.75%
Revenue Next Year-10.08%
Revenue Next 2Y-0.9%
Revenue Next 3Y-0.83%
Revenue Next 5Y0.78%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A